In a human intervention study involving individuals with borderline dyslipidemia, daily consumption of pine leaf extract, including the bark, at a dose of 1200 mg for 12 weeks resulted in a significant decrease in the VLDL cholesterol concentration and a significant increase in SOD activity compared to those in the placebo group after consumption [29]. Here, SOD1 is linked to metabolic syndrome.